September 06, 2023 at 03:16PM Recommendations for the Use of Clinical Data in Premarket Notification [510(k)] Submissions

This guidance provides information for situations when clinical data may be necessary to demonstrate substantial equivalence in a 510(k) submission.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/8Fk0GqD